John Mark O'Mahony insider trades
Open-market stock purchases and sales by John Mark O'Mahony, Chief Manufacturing Officer at Leap Therapeutics, Inc, from SEC Form 4 filings since Apr 9, 2020.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- LPTX Leap Therapeutics, Inc: other filings, last Mar 28, 2025